A nontandem novel compound chimeric antigen receptor redirected to target CD20‐CD19 positive B‐cell acute leukemias and B‐cell lymphoma.
Saved in:
| Title: | A nontandem novel compound chimeric antigen receptor redirected to target CD20‐CD19 positive B‐cell acute leukemias and B‐cell lymphoma. |
|---|---|
| Authors: | DeStefano, Vincent M1 (AUTHOR), Wada, Masayuki1 (AUTHOR), Pinz, Kevin G1 (AUTHOR), Assi, Rita2 (AUTHOR), Zhang, Hongyu3 (AUTHOR), Wang, Weijia4 (AUTHOR), Zhang, Wenli3 (AUTHOR), Shah, Darshi1 (AUTHOR), Ma, Yupo1 (AUTHOR) yupo.ma@icellgene.com, Salman, Huda5 (AUTHOR) hsalman@iu.edu |
| Source: | Clinical & Translational Medicine. Jul2024, Vol. 14 Issue 7, p1-6. 6p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 20011326 |
|---|---|
| DOI: | 10.1002/ctm2.1743 |
